Christopher Richard Anzalone, Chief Executive Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 199,977 shares at $38.81 ($7.8M) on 2020-06-25, disclosed to the SEC on 2020-06-26.
Open-market sale of $7.8M ARWR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.81 | 99,977 | $3.9M | 50.0% |
| 2 | $38.81 | 99,977 | $3.9M | 50.0% |
| 3 | $39.55 | 23 | $910 | 0.0% |
| Total | $38.81 avg | 199,977 | $7.8M | 100% |
| Filing → |
| ARWR | SELL | 2025-12-23 | $3.5M | — | Filing → |
| ARWR | SELL | 2025-12-19 | $10.9M | — | Filing → |
| ARWR | SELL | 2025-12-16 | $24.6M | — | Filing → |